Literature DB >> 6601612

Analysis of the binding of peanut agglutinin (PNA) to leukaemic cells and its relationship to T-cell differentiation.

R A Newman, D Delia.   

Abstract

Several leukaemias have been screened with a panel of monoclonal antibodies as well as fluoresceinated peanut lectin (FITC-PNA). Approximately 25% of T-acute lymphoblastic leukaemias (T-ALLs) were strongly positive with FITC-PNA. The staining distribution pattern did not correlate with any other monoclonal antibody used, although the phenotypes of the PNA+ T-ALLs were similar to those found on cortical thymocytes and probably reflect a more mature cellular phenotype within the T-ALL group. Some myeloid leukaemias were also PNA+ although the staining was generally weak. Several T-cell lines were examined and generally the TdT- lines showed strongest fluorescence after incubation with FITC-PNA. If these lines were induced to differentiate with 12-O-tetradecanoyl phorbol 13-acetate (TPA) they became PNA-. This was accompanied by an increase in cellular sialyl transferase activity, suggesting that one step in the differentiation process of "early' T cells is the terminal sialylation of existing oligosaccharide chains. Metabolic labelling of PNA+ T-cell lines with [35S]-methionine followed by detergent lysis and affinity chromatography on PNA-agarose showed that several bands of molecular weights 40-100,000 were bound to the column when examined by sodium dodecyl sulphate polyacrylamide gel electrophoresis. If TPA-treated cells were examined these bands were absent.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601612      PMCID: PMC1454111     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  Sialic acids and sialyltransferases in murine lymphoid cells: indicators of T cell maturation.

Authors:  J P Despont; C A Abel; H M Grey
Journal:  Cell Immunol       Date:  1975-06       Impact factor: 4.868

2.  Hemopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins.

Authors:  Y Reisner; L Itzicovitch; A Meshorer; N Sharon
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

Review 3.  Patterns of gene expression and the cellular origins of human leukaemias.

Authors:  M Greaves; G Janossy
Journal:  Biochim Biophys Acta       Date:  1978-10-27

4.  T-lymphocyte differentiation is accompanied by increase in sialic acid content of Thy-1 antigen.

Authors:  D Hoessli; C Bron; J R Pink
Journal:  Nature       Date:  1980-02-07       Impact factor: 49.962

5.  Interaction of peanut agglutinin with normal human lymphocytes and with leukemic cells.

Authors:  Y Reisner; M Biniaminov; E Rosenthal; N Sharon; B Ramot
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

Review 6.  The immunological classification of acute lymphoblastic leukemias.

Authors:  J C Brouet; M Seligmann
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

7.  Peanut agglutinin. I. A new tool for studying T lymphocyte subpopulations.

Authors:  J London; S Berrih; J F Bach
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

8.  Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage.

Authors:  E L Reinherz; P C Kung; G Goldstein; R H Levey; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

9.  Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin.

Authors:  R Sutherland; D Delia; C Schneider; R Newman; J Kemshead; M Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

10.  Initial prognostic factors and lymphoblast-erythrocyte rosette formation in 109 children with acute lymphoblastic leukemia.

Authors:  L W Dow; L Borella; L Sen; R J Aur; S L George; A M Mauer; J V Simone
Journal:  Blood       Date:  1977-10       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.